Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Antitrust Laws
Pharma
Drugmakers dig in their heels amid FTC's latest patent crackdown
Companies that face FTC challenges against their Orange Book listings have opted not to remove any patents.
Angus Liu
Jun 25, 2024 9:20am
Appeals court backs Regeneron's antitrust suit against Novartis
Mar 19, 2024 10:40am
FTC takes patent scrutiny to Sanofi, Mylan's insulin case
Nov 21, 2023 11:34am
Pfizer and more must face 'overarching conspiracy' claims
Mar 1, 2023 11:25am
Novartis HQ raided in competition probe
Sep 15, 2022 10:50am
